jcp conference-coverage

Conference Coverage

Nicolas Ferreyros, Community Oncology Alliance.

Videos

Updates from Washington Impacting Community Oncology Practices

11/15/2023

Featuring Nicolas Ferreyros

In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.

In this interview, Nicolas...

11/15/2023

Cancer Care Business Exchange

Lindsay Kehoe, Clinical Trial Transformation Initiative.

Videos

Clinical Trials in the Community Setting Re-Envisioned

11/15/2023

Featuring Lindsay Kehoe

Lindsay Kehoe, MS, CGC, from Duke University/Clinical Trial Transformation Initiative, details her session on clinical trials in the community setting at the 2023 CPC & CBEx conference.

Lindsay Kehoe, MS, CGC, from...

11/15/2023

Journal of Clinical Pathways

Ruben A. Mesa, MD, FACP, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Videos

Novel Advances in the Treatment of Patients With Myelofibrosis

11/07/2023

Featuring Ruben A. Mesa, MD, FACP

Featuring Ruben A. Mesa, MD, FACP ...

At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Ruben A. Mesa, MD, FACP, discusses the latest updates in myelofibrosis treatment.

At the 2023 Lymphoma, Leukemia &...

11/07/2023

Lymphoma, Leukemia & Myeloma Network

Videos

What the Growth of Medicare Advantage Means for Value-Based Care in Community Oncology

11/06/2023

Featuring David Eagleton

David Eagleton, Oncology Care Partners, shares his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care.

David Eagleton, Oncology Care...

11/06/2023

Journal of Clinical Pathways

Videos

How Technologies and New Models Are Changing Clinical Research

11/02/2023

Featuring Sibel Blau, MD

Sibel Blau, MD, provides insights into the current state of clinical research in the oncology community and how technologies and new models are impacting this area.

Sibel Blau, MD, provides...

11/02/2023

Journal of Clinical Pathways

News

Tracking Cost of Care Discussions Between Physicians and Patients with NSCLC and Melanoma

10/30/2023

Grace Taylor

Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.

Robin Yabroff, PhD, MBA, and...

10/30/2023

Journal of Clinical Pathways

News

Do Medically Integrated Pharmacies Reduce the Abandonment Rate of Oral Anticancer Medications?

10/30/2023

Emry Lloyd

Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.

Dr Doshi and colleagues measured...

10/30/2023

Journal of Clinical Pathways

News

The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs

10/28/2023

Grace Taylor

Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.

Puneeth Indurlal, MD, MS, and...

10/28/2023

Journal of Clinical Pathways

News

How Well Does the Enhancing Oncology Model Capture Treatment Costs in Disease Groups?

10/27/2023

Emry Lloyd

Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.

Katherine Baker, MD, and...

10/27/2023

Journal of Clinical Pathways

News

The Impact of Dosing Approaches for Lenalidomide on Total Cost of Care

10/27/2023

Grace Taylor

Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.

Puneeth Indurlal, MD, MS, The US...

10/27/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products